Skip to main content

Table 3 Cardiovascular risk parameters

From: Analysis of a sample of type 2 diabetic patients with obesity or overweight and at cardiovascular risk: a cross sectional study in Spain

Cardiovascular risk components

Values in the sample mean ± SD [95% CI]

Reference values

Percentage values of the sample within reference

BMI

34.8 ± 5.8 [32.9-36.7]

18.5-24.91

0% (n = 0)

Weight (kg)

85.5 ± 14.9 [80.6-90.4]

  

Waist circumference (cm)

106.7 ± 12.2 [102.7-110.7]

< 88 females/102 males2

5.3% (n = 2) females/13.2% (n = 5) males

SBP (mmHg)

133.6 ± 13.8 [128.4-138.9]

< 1401

47.4% (n = 18)

DBP (mmHg)

79.3 ± 5.9 [7781.–6]

< 901

68.4% (n = 26)

Glucose (mg/dl)

141.3 ± 40.7 [127.5-155]

< 1003

11.1% (n = 4)

Total cholesterol (mg/dl)

171.9 ± 23.4 [164180]–

< 2001

91.7% (n = 33)

HDL-c (mg/dl)

56.8 ± 11 [5360.–5]

> 501

66.7% (n = 24)

LDL-c (mg/dl)

92.1 ± 20.7 [85.2-99.1]

< 1301

89.5% (n = 34)

Triglycerides (mg/dl)

123.1 ± 76.7 [97.2-149]

< 2001

91.7% (n = 33)

HbA1c (%)

6.8 ± 1.3 [6.3-7.2]

< 7%3

44.7% (n = 17)

Fibrinogen (mg/dl)

339.3 ± 85.8 [309.8-368.8]

200-4004

77.1% (n = 27)

us-CRP (mg/L)

6.3 ± 7.4 [3.8-8.8]

< 31

44.7% (n = 17)

  1. 1SEEDO 2007, 2ATP III 2002, 3ADA 2012, 4Gailani D, Neff AT 2008.
  2. ADA = American Diabetes Association; ATPIII: adult treatment panel III; BMI = body mass index; HbA1c = glycosylated hemoglobin; HDL-c = high-density lipoprotein cholesterol; LDL-c = low-density lipoprotein cholesterol; SEEDO = Spanish Society for the Study of Diabetes and Obesity; us-CRP = ultrasensitive C reactive protein.